Imaging AI in New Jersey

Canfield Scientific is a global leader in medical imaging systems, software, and clinical research services founded in 1986. The company specializes in advanced 3D and 2D imaging solutions for dermatology, plastic surgery, and aesthetic medicine practices. Core offerings include the VISIA complexion analysis system (skin assessment and hyperpigmentation detection), VECTRA whole-body 3D imaging platforms (body mapping and surgical planning), VEOS portable dermoscopy systems, D2 dermoscopy software, and IntelliStudio software suites for clinical documentation and patient communication. Canfield serves pharmaceutical, biotechnology, cosmetic, and healthcare sectors globally through a network of partners in over 50 countries, providing integrated imaging documentation, clinical analysis services, and AI-assisted diagnostic tools to support treatment planning and patient outcomes.

Clario (formerly Bioclinica) is a global clinical trial endpoint technology platform and services provider with 50+ years of expertise supporting drug development. The company delivers comprehensive solutions for efficacy, safety, and patient quality-of-life assessments across decentralized, hybrid, and site-based clinical trials in over 100 countries. Clario's integrated platform combines clinical trial management software, connected medical devices, and AI-powered solutions spanning cardiac safety monitoring, electronic clinical outcomes assessment (eCOA), medical imaging with imaging core lab services, precision motion analysis, and respiratory endpoints. With experience managing 30,000+ trials contributing to 700+ FDA/EMA new drug approvals, Clario employs 3,900+ professionals including 200+ therapeutic area specialists. The platform emphasizes regulatory compliance, patient-centric design, global multilingual deployment, and 24/7 operational support to simplify trial processes for sponsors, contract research organizations (CROs), and research sites.

b-rayZ AG is a Swiss AI-powered medical software company specializing in breast imaging diagnostics and workflow optimization. The company develops a modular, end-to-end platform that integrates AI technology with clinical expertise to standardize, automate, and digitalize breast diagnostic processes. b-rayZ's ecosystem addresses inefficient workflows, staff shortages, and misdiagnosis risks by delivering real-time results with automatic BI-RADS ACR and Image Quality classifications. The platform is designed to support patients throughout their entire diagnostic journey and can be seamlessly integrated into existing IT infrastructure and imaging device systems. Key capabilities include automated quality assurance checks, standardized procedures, and physician-supported decision-making. The company serves radiological networks, imaging institutes, healthcare professionals, and patients across Europe and beyond, with notable strategic partnerships including Affidea Group, Biotronics3D, SC PACS Bulgaria, and Medecom. b-rayZ holds CE marking certification and ISO 13485 compliance (DQS MED), indicating adherence to medical device regulatory requirements. The company is headquartered in Switzerland and describes itself as Swiss-made software, with products tailored for both institutional clinical efficiency and personalized patient care approaches.

Nano-X Imaging Ltd is a medical imaging company specializing in digital tomosynthesis and AI-driven diagnostic solutions. The company develops and markets FDA-cleared and CE-marked imaging systems featuring proprietary cold cathode X-ray technology. Primary product lines include Nanox.ARC and Nanox.ARC X, both digital multi-source 3D tomosynthesis systems designed for advanced radiographic visualization. Nanox.AI solutions provide FDA-cleared artificial intelligence capabilities targeting asymptomatic disease detection across cardiac, bone, and liver pathology. The platform leverages Nanox.SOURCE, a silicon-based, low-voltage, nano-scale cold cathode using field-emission technology to generate X-ray electron streams. Nanox.MARKETPLACE is a cloud-based diagnostic platform connecting imaging providers and facilities globally. The company serves hospital systems, imaging centers, and outpatient facilities, with collaborations including Varex, CSEM, Vieworks, NHS, Oxford University, and others. Products address radiography, tomosynthesis, and AI-assisted diagnostics. The company maintains a clinically driven approach with validation from academic radiologists and deployment across multiple healthcare settings.

Infervision is a global medical artificial intelligence company founded in 2015, specializing in deep learning technologies for medical imaging and clinical diagnostics. Headquartered in Beijing with a US office in Lyndhurst, New Jersey, Infervision develops AI-powered platforms designed for radiologists and clinicians to enhance diagnostic accuracy and clinical workflows. The company's InferRead™ suite processes over 33,000 exams daily and provides comprehensive imaging analysis across multiple organ systems including lungs, cardiovascular, breast, and bone. InferOperate™ offers surgical planning and intraoperative navigation, while InferScholar™ and InferMatrix™ platforms support medical research and innovation. Infervision's solutions assist in detecting conditions such as lung cancer, stroke, pneumonia, tuberculosis, and fractures from various imaging scans. The company holds regulatory approvals from the US FDA, China NMPA, EU CE, UK UKCA, and Japan PMDA, with products deployed across 1,000+ medical institutions in 30+ countries.

AGFA HealthCare is a global leader in enterprise imaging and diagnostic imaging software solutions serving healthcare organizations worldwide. The company develops and delivers an integrated Enterprise Imaging platform that consolidates PACS (Picture Archiving and Communication Systems), imaging analytics, and clinical workflows across multiple imaging modalities including radiology, cardiology, breast imaging, molecular imaging, digital pathology, POCUS (point-of-care ultrasound), teleradiology, medical photography, and specialty areas including dental, ophthalmology, and orthopedics. The Enterprise Imaging platform is engineered around clinician-first design principles, offering seamless workflow integration, blazing-fast streaming access, and specialty-tailored clinical workspaces. Key product components include: Streaming Client (web-based diagnostic access), XERO Universal Viewer (patient-centric cross-specialty imaging), Vendor Neutral Archive (VNA) for multimedia data consolidation, RUBEE AI (augmented intelligence ecosystem), RUBEE Orchestrator (workflow automation and orchestration), Business Intelligence tools, and Enterprise Imaging Scheduling. AGFA HealthCare delivers solutions across multiple deployment models: on-premises, cloud (SaaS), and hybrid architectures, utilizing cloud-native microservices. The platform is built with security-by-design principles, incorporating encryption, access control, auditing, and compliance frameworks. The company serves hospitals, health networks, and healthcare organizations of varying digital maturity and scale, from individual facilities to large enterprise systems. Services include hands-on onboarding, role-specific training programs, clinical coaching, customer experience center collaboration, CE credit programs, and 24/7 operational support. AGFA HealthCare has received recognition as "Best in KLAS" for 2026 across multiple enterprise imaging segments and maintains established partnerships and deployments globally.

PathPresenter is an enterprise-grade digital pathology image management and workflow platform founded in 2017 by Dr. Rajendra Singh, a dermatopathologist and digital pathology pioneer. The platform serves pathologists and medical institutions with FDA 510(k)-cleared and CE-IVDR certified clinical viewers for primary diagnosis and consultations. PathPresenter offers comprehensive modules including clinical care, enterprise education, biorepository management for research data, and remote consultation capabilities via ConsultConnect. The system emphasizes vendor-agnostic interoperability, supporting any scanner, storage platform, laboratory information system (LIS), and third-party AI models. Key features include optimized pathologist workflows, voice control integration, powerful slide administration, and seamless integration across institutional systems. With over 50,000 users across 172 countries and adoption by more than 50 top-tier hospitals, laboratories, and pharmaceutical companies, PathPresenter combines clinical performance with AI readiness, enterprise integration, and education leadership. The platform powers the College of American Pathologists' AI Studio, enabling testing of cutting-edge AI tools in realistic scenarios with whole slide images.